Your expert for mRNA therapeutics and cell and gene therapy products

CATUG Biotechnology is dedicated to advancing mRNA therapeutics and cell and gene therapies by offering comprehensive, streamlined solutions from development through to commercialization. Guided by a skilled team and housed in state-of-the-art R&D and manufacturing facilities, CATUG partners closely with clients to accelerate the journey from initial research to patient access. Their mission centers on ensuring quality, compliance, and efficiency at every phase, making each client’s success their own priority.

Molecular biology
Services
Website

CatPure mRNA products

  • Each mRNA has been fully sequence optimized (CDS+UTR) and screened from more than 20 variants for the highest expression.
  • Each mRNA is produced with strictly controlled IVT, oligo-dT purification, and TFF process to minimize bath-to-batch variation.
  • The quality of each batch is fully analyzed and controlled with IND-grade release specification and confirmed with in vitro and cell potency.
  • Each catalog mRNA has been greatly tested and validated among academic and industrial clients in a wide range of applications.
  • In-house technology for dsRNA removal dramatically reduces the immunogenicity of mRNA therapeutics.

CatPure LNP products

Lipid nanoparticles (LNP) are a commonly used delivery vehicle that can facilitate transfection of encapsulated mRNA in cells. After endosomal escape, mRNA is released and translated into the protein of interest.

CATUG’s high quality LNP products are developed using the approved Moderna COVID-vaccine formulation consisting of SM-102 ionizable lipid, DSPC, PEG-DMG-2000, and cholesterol. Their mRNA-LNP product offerings currently focus on reporter genes such as firefly luciferase, mCherry, and EGFP. However, CATUG also take custom requests for your specific mRNA and LNP formulation of interest.

Custom manufacturing services

CATUG provide contract research, development, analytical and GMP manufacturing services ranging from plasmid DNA, mRNA, lipid nanoparticle (LNP), and analytical quality control (QC). CATUG's strong technical platforms, expertise and know-how aim to present end-to-end solutions to clients in the whole life cycle of nucleic acid drug development. 

Contact us for more information        More about our custom service offering